PEDIATRIC FORMULATIONS 2ND EDITION - A ROAD MAP

PEDIATRIC FORMULATIONS 2ND EDITION

A ROAD MAP

Written in cooperation with the EuPFI -European Pediatric Formulation Initiative and the AAPS

Lire la suite keyboard_arrow_right

Auteur(s) Hannah Batchelor, Klaus Rose
Éditeur SPRINGER
Date 17/02/2026
Pages 475
Taille 15 x 23
Type Relié
Langue Anglais
ISBN 9783031772399

Description détaillée : PEDIATRIC FORMULATIONS 2ND EDITION

Since the first edition in 2014 pediatric drug development has expanded in several dimensions. There have been significant changes on the technical level, as have been in the assessment of the regulatory demands.

This 2nd edition gives an overview and update on both aspects.

This is not a “how to formulate“ textbook, but an attempt to equip the reader with necessary information on the technical, the regulatory, and the historical level.

Who are the Authors of "Pediatric Formulations 2nd Edition" ?

Professor Hannah Batchelor is a pharmaceutical scientist who has worked in academia, the NHS and within pharmaceutical industry. She is currently based at the Strathclyde Institute of Pharmacy and Biomedical Science, University of Strathclyde in Glasgow. She is Director of Research for the Strathclyde Institute of Pharmacy and Biomedical Sciences.

She works on the design and manipulation of medicines to create age appropriate drug formulations to maximise clinical efficacy in paediatric patients. Her research interests lie in the optimisation of drug formulations to maximise their biopharmaceutical performance and acceptability to children. Her research is informed by the views of children, young people and parents to ensure that the patients are at the centre of new developments. She is also the director of the GIBio facility at Strathclyde which is an advanced dissolution apparatus designed to provide near clinical data to inform formulation development.

Hannah is passionate about pharmaceutical sciences and is motivated to inspire the next generation of scientists.

Dr. Klaus Rose is CEO of klausrose Consulting, Switzerland and advises on pediatric drug development and how to comply with FDA and EMA pediatric requirements. He has studied Latin languages, psychology and medicine. After postgraduate clinical training in general medicine in Germany and England, he joined the pharmaceutical industry.

He has held various positions in R&D and medical affairs, was Global Head Pediatrics Novartis from 2001 to 2005 and was Global Head Pediatrics Roche from 2005 to 2009. After a year with a regulatory consultancy, he established his own business.

Dr. Rose is a frequent speaker on international conferences on pediatric drug development, organizes trainings and publishes on a regular base.

À PARAÎTRE OU DERNIÈRE PARUTION DANS LA MÊME CATÉGORIE :

148,00 €

Sur commande

Expédition sous 20 à 30 jours

148,00 €

Bénéficiez de la remise de 5% en choisissant le retrait en magasin

 
Livraison à 0.01€ à partir de 35€

d'achats en France Métropolitaine

 
Satisfait ou remboursé

sous 14 jours ouvrés

 
Paiements sécurisés

 
Service client

Lundi au Vendredi : de 10h à 18h30
au 04 67 63 62 19 ou par email